epm Therapeutics
Biotechnology Research • 
Florence, Kentucky, United States • 1-10 Employees
Company overview
| Headquarters | 7310 Turfway Rd, Suite 550, Florence, Kentucky 41042, US |
| Phone number | +18596483367 |
| Website | |
| NAICS | 541714 |
| Founded | 2017 |
| Employees | 1-10 |
Key Contact at epm Therapeutics
Phil Rose
President and COO
About epm Therapeutics
epm Therapeutics is a biotechnology company developing synthetic cannabinoid acid derivatives. Our singular dedication is researching and developing the potential of our EPM301 to improve the symptoms of hyperphagia (uncontrolled appetite) in patients with PWS (Prader-Willi Syndrome) and improve their quality of life as well as that of their dedicated caregivers.
epm Therapeutics revenue & valuation
| Annual revenue | $85,555 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $273,776 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
epm Therapeutics has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
epm Therapeutics has never raised funding before.
epm Therapeutics Tech Stack
Discover the technologies and tools that power epm Therapeutics's digital infrastructure, from frameworks to analytics platforms.
Security
JavaScript libraries
Hosting
Analytics
Reverse proxies
Security
Miscellaneous
JavaScript libraries
Miscellaneous
Performance
CMS
Poland
United Kingdom
France
AustraliaFrequently asked questions
4.8
40,000 users
